• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [72 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 NIHR Health Technology Assessment programme Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation
2023 NIHR Health Technology Assessment programme Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023 NIHR Health Technology Assessment programme Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis
2023 National Institute for Health and Care Excellence (NICE) FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care. NICE diagnostics guidance 48
2022 National Institute for Health and Care Excellence (NICE) Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis. NICE interventional procedures guidance 746
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: initiating pharmacotherapy for relapse prevention in a person with alcohol use disorder]
2021 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Recommendations for the appropriate use of vitamin D tests and supplements in the general population]
2020 NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020 Agency for Care Effectiveness (ACE) Ursodeoxycholic acid for treating primary biliary cirrhosis
2019 Institute for Clinical Effectiveness and Health Policy (IECS) [Shear-wave elastography for liver fibrosis]
2018 Penn Medicine Center for Evidence-based Practice (CEP) Transjugular Intrahepatic Portosystemic Shunts for Patients with Acute Variceal Bleeding
2018 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Diagnostic effectiveness and safety of elastography in liver fibrosis]
2018 National Institute for Health and Care Excellence (NICE) Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis. NICE interventional procedures guidance 631
2017 Andalusian Health Technology Assessment Area (AETSA) Direct acting antivirals for the chronic hepatitis C infection. Relative assessment of efficacy and safety. Executive summary
2017 Canary Health Service [Early detection of hepatocarcinoma in patients at risk]
2017 Canary Health Service [Cost-effectiveness of pneumococcal vaccination in adults older than 60 years]
2016 NIHR Horizon Scanning Centre (NIHR HSC) Doxorubicin-eluting beads (DC Bead, DC Bead M1 and Radiopaque DC Bead) for hepatocellular carcinoma
2016 NIHR Horizon Scanning Centre (NIHR HSC) ADI-PEG 20 for hepatocellular carcinoma – second line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Glecaprevir with pibrentasvir for chronic hepatitis C infection, genotypes 1, 2, 3, 4, 5 and 6
2016 NIHR Horizon Scanning Centre (NIHR HSC) Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2016 Adelaide Health Technology Assessment (AHTA) Enhanced liver fibrosis test
2015 NIHR Health Technology Assessment programme Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Daclatasvir (Daklinza®)
2015 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ledipasvir/sofosbuvir (Harvoni®)
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Sofosbuvir and simeprevir-based schemes for the management of hepatitis C]
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Ombitasvir, paritaprevir and ritonavir regimens in hepatitis C patients]
2015 NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacoeconomic review report. Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir (Sovaldi — Gilead Sciences Canada, Inc.) indication: chronic hepatitis C infection
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Aripiprazole (Abilify — Bristol-Myers Squibb Canada) new indication: major depressive disorder
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ombitasvir/paritaprevir/ritonavir and dasabuvir
2014 Haute Autorite de sante (HAS) [Assessment of non-invasive methods for measuring liver fibrosis in chronic hepatitis B. Initial assessment and follow-up of non-treated adult patients]
2013 NIHR Health Technology Assessment programme Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study
2013 HAYES, Inc. Interleukin 28B (IL28B) testing to predict response to treatment of hepatitis C virus (HCV) infection
2013 NIHR Horizon Scanning Centre (NIHR HSC) Obeticholic acid for primary biliary cirrhosis – second line
2012 NIHR Horizon Scanning Centre (NIHR HSC) ALFApump® System for ascites due to liver cirrhosis
2012 HAYES, Inc. Aquamantys system with transcollation technology (Medtronic Inc.) for liver resection
2012 HAYES, Inc. Argon plasma coagulation for hemostasis in patients with gastric antral vascular ectasia (GAVE)
2012 HAYES, Inc. Doxorubicin drug-eluting bead transarterial chemoembolization (DEB-TACE) for patients with hepatocellular carcinoma (HCC)
2012 Andalusian Health Technology Assessment Area (AETSA) [Protease inhibitors (Boceprevir and telaprevir) in the treatment of chronic HCV infection: relative efficacy, safety and efficiency]
2012 HTA Unit, University of Calgary A health technology assessment of transient elastography in liver disease
2011 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Tolvaptan (Samsca) for the treatment of hyponatremia associated with the syndrome of inappropriate antidiuretic hormone secretion]
2011 HAYES, Inc. Percutaneous ethanol ablation for hepatocellular carcinoma
2010 HAYES, Inc. FIBROSpect II test (Prometheus Laboratories Inc.) for diagnosis of liver fibrosis in patients with hepatitis c
2010 Medical Services Advisory Committee (MSAC) Assessment of liver iron by R2 - Medical Resonance Imaging (MRI) data analysis
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Albumin versus synthetic plasma volume expanders: a review of the clinical and cost-effectiveness and guidelines for use
2009 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2008 Agency for Healthcare Research and Quality (AHRQ) Management of chronic hepatitis B
2008 Committee for New Health Technology Assessment (CNHTA) [Autologous bone marrow cell infusion for advanced liver cirrhosis]
2007 NIHR Health Technology Assessment programme Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2006 NIHR Health Technology Assessment programme Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation
2006 Canadian Agency for Drugs and Technologies in Health (CADTH) Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis
2006 Blue Cross Blue Shield Association (BCBS) Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients
2005 Institute for Clinical Systems Improvement (ICSI) Gastric restrictive surgery for clinically severe obesity in adults
2005 Institute for Clinical Systems Improvement (ICSI) Antiviral treatment for chronic hepatitis C
2005 HAYES, Inc. Sclerotherapy for esophageal varices
2004 Agency for Healthcare Research and Quality (AHRQ) Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use
2004 Agency for Healthcare Research and Quality (AHRQ) Screening for hepatitis C virus infection
2004 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Clinical and economic assessment of screening for HFE1 haemochromatosis in 2004
2004 Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with pegylated interferon in hepatitis C
2003 Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with interferon in hepatitis C
2002 Agency for Healthcare Research and Quality (AHRQ) Management of chronic hepatitis C
2002 Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C?
2002 Institute for Clinical Systems Improvement (ICSI) Antiviral therapy for chronic hepatitis C
2001 NIHR Horizon Scanning Centre (NIHR HSC) Pegylated interferon alfa for hepatitis C - horizon scanning review
2000 Agency for Healthcare Research and Quality (AHRQ) Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects
1997 Alberta Heritage Foundation for Medical Research (AHFMR) Percutaneous ethanol injection therapy as a treatment for hepatic cancer
1995 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Indications and contraindications of the liver transplantation and retransplantation - expert panel. IPE-95/04 (Public report)
1993 Health Council of the Netherlands Gezondheidsraad (GR) Planning liver transplantations. Critical remarks on a draft-regulation
1991 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis